Supported through an unrestricted educational grant
from Novo Nordisk Pharmaceuticals, Inc.
 

Blood Glucose Monitoring

Please read the following information and select the appropriate link at the bottom of the page to continue.

Target Audience: Pharmacists, nurses, and dietitians who are involved with patient education and counseling

Goal: To increase awareness of the role of blood glucose monitoring in the management of diabetes and to provide information that will improve the prognosis of patients with diabetes

Educational Objectives: Upon completion of this activity participants should be able to:

  • Discuss the prevalence of diabetes and risk of complications
  • Describe the history of targeted glucose testing
  • Explore the benefits of targeted glycemic control
  • State the importance of empowering patients to manage diabetes
  • Identify and discuss currently marketed glucose monitors and identify key features of different glucose monitors
  • Discuss the importance of pattern management

Pharmacists: The American Association of Diabetes Educators and Novo Nordisk Pharmaceuticals, Inc. are accredited by the American Council on Pharmaceutical Education (ACPE) as providers of continuing pharmaceutical education. This program provides for 1.25 contact hours (.125 CEUs). ACPE Universal Program Number 069-360-02-871-H04

Registered Nurses: This program for 1.5 contact hours has been approved by the American Association of Diabetes Educators which is accredited as an approver of continuing education in nursing by the American Nurses Credentialing Center's Commission of Accreditation. Approval of this continuing education activity does not imply endorsement by AADE. Approval number 0203-013

Dietitians: American Association of Diabetes Educators (AM001) is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR) from June 1, 2003 to May 31, 2006. Registered dietitians (RD) and dietetic technicians, registered (DTR) will receive 1.0 Continuing Professional Education Units (CPEUs) for completion of this program. Continuing Professional Education Provider Accreditation does not constitute endorsement by CDR of a provider, program, or materials.

Initial Release Date: 12/03/02
Planned Expiration Date: 12/03/04

To receive a statement of credit, you must:

  • Successfully complete the post-test (70% or better).
  • Complete the program evaluation.

Your statement of credit will be issued immediately upon successful completion of the test and submission of the evaluation form. The statement of credit specific to your discipline will appear on your screen and you will be given the option to print it for your files. No additional statement of credit will be issued.

Activity Presenter:

Jerry Meece, R.Ph., F.A.C.A, C.D.E
Pharmacist and Certified Diabetes Educator
Owner and Director of Clinical Services:
Plaza Pharmacy And Wellness Center
Gainesville, Texas

The following program is a presentation by Jerry Meece.  Mr. Meece is a pharmacist and Certified Diabetes Educator who is owner and Director of Clinical Services of Plaza Pharmacy And Wellness Center in Gainesville, Texas. Mr. Meece has written many articles on diabetes care and insulin use in the patient with diabetes. He has also spoken across the country on the subject of diabetes and disease state management in the pharmacy setting. Mr. Meece currently serves on the Board of Directors for the American Association of Diabetes Educators and is also chairman of the Public Affairs Committee for that organization.

Fee: There is no fee to receive credits for this program.

Commercial Supporter: This program has been supported through an unrestricted educational grant from Novo Nordisk Pharmaceuticals, Inc.

Trademarks:

Precision Xtra and Sof-Tact trademarks of Abbott Laboratories.
Precision QID registered trademark of Abbott Laboratories.
Glucometer Elite XL, Glucometer Elite, and Glucometer DEX2 registered trademarks of Bayer Corporation Diagnostics.
Supreme II, Assure, and Select GT registered trademarks of Hypoguard USA, Inc.
One Touch Ultra, One Touch Profile, and One Touch SureStep registered trademarks of LifeScan, Inc, a Johnson and Johnson company.
In Charge and ExpressView trademarks of LXN Corporation.
Duet registered trademark of LXN Corporation.
Accu-Chek Active, Accu-Chek Advantage, and Accu-Chek Complete registered trademarks of Roche Diagnostics Corporation.
Prestige IQ and Prestige LX registered trademarks of Home Diagnostics, Inc.
FreeStyle registered trademark of TheraSense, Inc.
CheckMate Plus registered trademark of QuestStar Medical.
ReliOn registered trademark of Wal-Mart Stores, Inc.
Induo trademark of Life Scan, Inc., a Johnson & Johnson company.
GlucoWatch Biographer registered trademark of Cygnus, Inc.

Disclosure Declaration: It is the policy of Novo Nordisk Pharmaceuticals, Inc. and the American Association of Diabetes Educators to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their continuing education activities. The faculty must disclose to the participants any significant relationships with the commercial companies whose products or devices may be mentioned in the activity or with the supporter of this continuing education activity. The information is for participant information; it is not assumed that these relationships will have a negative impact on the content of the activity.

Jerry Meece has disclosed that he is a consultant for Eli Lilly and Company and LifeScan Inc., a Johnson and Johnson company. He is also on the speaker's bureau for Eli Lilly and Company, LifeScan, and Novo Nordisk Pharmaceuticals, Inc.

Disclaimers:

  • Approval of credit for this continuing education program does not imply endorsement by AADE of any product or manufacturer identified.
  • Any medications or treatment methods suggested in this CE activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.
  • This activity may include discussions of products or devices that are not currently approved for use by the Food and Drug Administration (FDA).
  • Novo Nordisk Pharmaceuticals, Inc., the American Association of Diabetes Educators, and the activity's faculty do not endorse the use of any product in a manner that is not approved by the FDA.

    The author, sponsor, and publisher of this continuing education program have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.

Click the appropriate profession to continue to the activity:

Pharmacists click here

Nurses click here

Dietitians click here

Copyright 2002 Novo Nordisk Pharmaceuticals, Inc. All rights reserved. 125734

 


For our Terms of Use and Privacy Policy, please review our Legal Agreement.
Copyright© 2004 CECity® All rights reserved.

HOME | HELP | EMAIL

NOTE: Real Player 8 or higher is required to view the slides & audio version of this activity.

Click here to download Real Player.

Adobe Acrobat is required to view the references and printable version of this activity.

Click here to download Adobe Acrobat Reader for FREE

NOTE TO MACINTOSH USERS:
In order to view the slides and audio portion of this activity, Netscape 7.0 or higher is required.


The slides and audio player will not operate in Microsoft Internet Explorer or earlier versions of Netscape on the MacIntosh.